M Ara - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M Ara

Showing results (91-100 of 93) with videos related to

Pageof 10

Sort By:

You have reached the last page of results.This site can display upto 93 results.

Actas Dermo-Sifiliograficas|March 7, 2024

Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional StudyA Martorell-Calatayud, S Santos-Alarcón, A Sahuquillo-Torralba, et al.

Actas Dermo-Sifiliograficas|October 27, 2023

Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD StudyM Sánchez-Díaz, Á Flórez, M Ara-Martín, et al.

Actas Dermo-Sifiliograficas|January 19, 2024

[Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD StudyM Sánchez-Díaz, Á Flórez, M Ara-Martín, et al.

Pageof 10

Search research articles

Showing results (91-100 of 93) with videos related to

Sort By:

Pageof 10

You have reached the last page of results.This site can display upto 93 results.

Actas Dermo-Sifiliograficas|March 7, 2024

Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional StudyA Martorell-Calatayud, S Santos-Alarcón, A Sahuquillo-Torralba, et al.

Actas Dermo-Sifiliograficas|October 27, 2023

Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD StudyM Sánchez-Díaz, Á Flórez, M Ara-Martín, et al.

Actas Dermo-Sifiliograficas|January 19, 2024

[Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD StudyM Sánchez-Díaz, Á Flórez, M Ara-Martín, et al.

Pageof 10